Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
32.40
+0.14 (0.43%)
Jan 21, 2026, 3:08 PM HKT
HKG:1501 Market Cap
HKG:1501 has a market cap or net worth of 5.65 billion as of January 20, 2026. Its market cap has increased by 18.50% in one year.
Market Cap
5.65B
Enterprise Value
5.81B
Revenue
1.01B
Ranking
n/a
PE Ratio
27.02
Stock Price
32.40
Market Cap Chart
Since November 8, 2019, HKG:1501's market cap has increased from 4.32B to 5.65B, an increase of 30.83%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 5.65B | 7.61% |
| Dec 31, 2025 | 5.25B | 3.09% |
| Dec 31, 2024 | 5.10B | 4.18% |
| Dec 29, 2023 | 4.89B | 1.25% |
| Dec 30, 2022 | 4.83B | 26.51% |
| Dec 31, 2021 | 3.82B | -43.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.48B |